• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Apotea

76.70 SEK

+1.46 %

Less than 1K followers

APOTEA

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.46 %
-4.24 %
+33.30 %
-16.83 %
-11.97 %
-20.25 %
-
-
-8.69 %

Apotea operates in the e-commerce sector and operates an online pharmacy. The company sells and delivers a wide range of prescription and non-prescription medicines, skin and hair care products, as well as makeup and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and is headquartered in Stockholm.

Read more
Market cap
8.1B SEK
Turnover
20.04M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
17.7.
2026

Interim report Q2'26

5.11.
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/29/2026, 5:30 AM

Number of shares and votes in Apotea

Apotea
Regulatory press release5/26/2026, 2:30 PM

Bulletin from Apotea AB’s (publ) Annual General Meeting on May 26, 2026

Apotea
Apotea, Webcast, Q1'26
Webcast4/29/2026, 7:30 AM

Apotea, Webcast, Q1'26

Apotea

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release4/29/2026, 5:30 AM

Apotea AB (publ) interim report Q1 2026: Strong operating profit and stable growth

Apotea
Regulatory press release4/17/2026, 9:05 AM

Notice to annual general meeting in Apotea AB (publ)

Apotea
Regulatory press release4/17/2026, 5:30 AM

Apotea publishes annual and sustainability report for the financial year 2025

Apotea
Press release4/7/2026, 7:00 AM

Invitation to Apotea’s Q1 2026 webcast

Apotea
Regulatory press release3/31/2026, 1:00 PM

The Nomination Committee's proposal for the Board of Directors of Apotea AB (publ)

Apotea
Apotea, Webcast, Q4'25
Webcast2/4/2026, 8:30 AM

Apotea, Webcast, Q4'25

Apotea
Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) Year-end report 2025: Weak profitability in the fourth quarter

Apotea
Regulatory press release1/28/2026, 1:39 PM

Apotea has recruited Joanna Hummel to accelerate the company’s growth initiatives

Apotea
Regulatory press release1/20/2026, 5:16 PM

Update regarding the fourth quarter of 2025

Apotea
Press release12/18/2025, 10:30 AM

Invitation to Apotea’s presentation of the year-end report 2025

Apotea
Apotea, Webcast, Q3'25
Webcast11/6/2025, 8:30 AM

Apotea, Webcast, Q3'25

Apotea
Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) Interim report Q3 2025: Successful production launch in Varberg and continued good profitability

Apotea
Press release10/3/2025, 8:00 AM

Invitation to Apotea’s Q3 2025 webcast

Apotea
Regulatory press release8/22/2025, 6:55 AM

Apotea: Employee representatives on the Board of Directors

Apotea
Apotea, Webcast, Q2'25
Webcast7/18/2025, 7:30 AM

Apotea, Webcast, Q2'25

Apotea
Regulatory press release7/18/2025, 5:30 AM

Apotea AB (publ) Interim report Q2 2025: Strengthened profitability and increased demand for prescription products

Apotea
Press release6/18/2025, 6:30 AM

Invitation to Apotea's Q2 2025 webcast

Apotea